These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16584167

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B, Khunt D, Misra M, Padh H.
    Pharm Res; 2018 Jan 02; 35(1):8. PubMed ID: 29294189
    [Abstract] [Full Text] [Related]

  • 24. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation.
    Masjedi M, Azadi A, Heidari R, Mohammadi-Samani S.
    J Pharm Pharmacol; 2020 Oct 02; 72(10):1341-1351. PubMed ID: 32579251
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Uptake and biodistribution of rizatriptan to blood and brain following different routes of administration in rats.
    Wang C, Quan LH, Guo Y, Liu CY, Liao YH.
    Int J Pharm; 2007 Jun 07; 337(1-2):155-60. PubMed ID: 17267150
    [Abstract] [Full Text] [Related]

  • 27. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL, Bharkad GP, Devarajan PV.
    Eur J Pharm Biopharm; 2015 Oct 07; 96():363-79. PubMed ID: 26318978
    [Abstract] [Full Text] [Related]

  • 28. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T.
    Headache; 2009 Jun 07; 49(6):817-25. PubMed ID: 19438727
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.
    Ramreddy S, Janapareddi K.
    Drug Dev Ind Pharm; 2019 Jan 07; 45(1):147-158. PubMed ID: 30230386
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X, Chi N, Tang X.
    Eur J Pharm Biopharm; 2008 Nov 07; 70(3):735-40. PubMed ID: 18684400
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.
    Lu W, Jiang W, Chen J, Yin M, Wang Z, Jiang X.
    Int J Pharm; 2008 Feb 12; 349(1-2):196-205. PubMed ID: 17904315
    [Abstract] [Full Text] [Related]

  • 36. Preparation of lorazepam-loaded microemulsions for intranasal delivery and its pharmacokinetics.
    Yao J, Hou L, Zhou JP, Zhang ZQ, Sun L.
    Pharmazie; 2009 Oct 12; 64(10):642-7. PubMed ID: 19947165
    [Abstract] [Full Text] [Related]

  • 37. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM, Pels LP, Mulder PG, Linssen WH, Gooskens RH, van der Zwan JL, Brouwer OF, SUM30042 Trial Group.
    Eur J Paediatr Neurol; 2007 Nov 12; 11(6):325-30. PubMed ID: 17428708
    [Abstract] [Full Text] [Related]

  • 38. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
    Patel S, Chavhan S, Soni H, Babbar AK, Mathur R, Mishra AK, Sawant K.
    J Drug Target; 2011 Jul 12; 19(6):468-74. PubMed ID: 20958095
    [Abstract] [Full Text] [Related]

  • 39. Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations.
    Cho HJ, Ku WS, Termsarasab U, Yoon I, Chung CW, Moon HT, Kim DD.
    Int J Pharm; 2012 Feb 28; 423(2):153-60. PubMed ID: 22209996
    [Abstract] [Full Text] [Related]

  • 40. Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting.
    Belgamwar VS, Patel HS, Joshi AS, Agrawal A, Surana SJ, Tekade AR.
    Drug Deliv; 2011 Jul 28; 18(5):353-60. PubMed ID: 21351825
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.